Drago L, Romano C
Front Microbiol. 2022; 12:814945.
PMID: 35345543
PMC: 8957080.
DOI: 10.3389/fmicb.2021.814945.
Burillo A, de Egea V, Onori R, Martin-Rabadan P, Cercenado E, Jimenez-Navarro L
Antimicrob Resist Infect Control. 2019; 8:176.
PMID: 31807286
PMC: 6857332.
DOI: 10.1186/s13756-019-0640-1.
Stokell J, Khan A, Steck T
J Clin Microbiol. 2014; 52(7):2340-5.
PMID: 24759710
PMC: 4097738.
DOI: 10.1128/JCM.00487-14.
Ganbo T, Hisamatsu K, Inoue H, Kikushima K, Mizukoshi A, Murakami Y
Mediators Inflamm. 1995; 4(5):350-4.
PMID: 18475663
PMC: 2365662.
DOI: 10.1155/S0962935195000561.
Pye A, Stockley R, Hill S
J Clin Pathol. 1995; 48(8):719-24.
PMID: 7560197
PMC: 502797.
DOI: 10.1136/jcp.48.8.719.
Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.
Hammerschlag M, Harding L, Macone A, Smith A, Goldmann D
J Clin Microbiol. 1980; 11(6):552-7.
PMID: 6776135
PMC: 273459.
DOI: 10.1128/jcm.11.6.552-557.1980.
Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.
Weller P, Ingram D, Preece M, Matthew D
Thorax. 1980; 35(1):42-6.
PMID: 6767295
PMC: 471218.
DOI: 10.1136/thx.35.1.42.
Clinical and physiological evaluation of mucolytic agents nebulized with soproterenol: 10 per cent N-acetylcysteine verus 10 per cent 2-mercaptoethane sulphonate.
Hirsch S, Viernes P, KORY R
Thorax. 1970; 25(6):737-43.
PMID: 4925508
PMC: 472218.
DOI: 10.1136/thx.25.6.737.
A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.
Ratjen F, Wonne R, Posselt H, Stover B, Hofmann D, Bender S
Eur J Pediatr. 1985; 144(4):374-8.
PMID: 3908111
DOI: 10.1007/BF00441781.
Glycoprotein analysis of middle ear effusions by rectin-conjugated sepharose affinity chromatography.
Sakakura K, Hamaguchi Y, Majima Y, Ukai K, Sakakura Y
Arch Otorhinolaryngol. 1986; 243(4):224-8.
PMID: 3778295
DOI: 10.1007/BF00464434.
Phosphorylcholine stimulates capsule formation of phosphate-limited mucoid Pseudomonas aeruginosa.
Krieg D, BASS J, Mattingly S
Infect Immun. 1988; 56(4):864-73.
PMID: 3126146
PMC: 259382.
DOI: 10.1128/iai.56.4.864-873.1988.
[Clinical-pharmacological studies on bronchosecretolysis].
Medici T, CHODOSH S
Pneumonologie. 1975; 152(1-3):25-44.
PMID: 1187396
DOI: 10.1007/BF02101571.
Use of a mucolytic agent (Cytoclair) in the preparation of cell material for the detection of malignant cells in sputum.
Grainger J, Husain O
J Clin Pathol. 1978; 31(6):585-90.
PMID: 670414
PMC: 1145348.
DOI: 10.1136/jcp.31.6.585.
The effect of sodium 2-mercapto-ethane sulphonate and hypertonic saline aerosols on bronchial clearance in chronic bronchitis.
Clarke S, Pavia D, Thomson M
Br J Clin Pharmacol. 1979; 7(1):39-44.
PMID: 104724
PMC: 1429616.
DOI: 10.1111/j.1365-2125.1979.tb00894.x.
